The use and misuse of risk prediction tools for clinical decision-making
Main Authors: | Marissa C. van Maaren, Tom A. Hueting, Vinzenz Völkel, Marjan van Hezewijk, Luc JA. Strobbe, Sabine Siesling |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2023-06-01
|
Series: | Breast |
Online Access: | http://www.sciencedirect.com/science/article/pii/S0960977623000061 |
Similar Items
-
External validation of 87 clinical prediction models supporting clinical decisions for breast cancer patients
by: Tom A. Hueting, et al.
Published: (2023-06-01) -
Explainable machine learning can outperform Cox regression predictions and provide insights in breast cancer survival
by: Arturo Moncada-Torres, et al.
Published: (2021-03-01) -
Facilitating validation of prediction models: a comparison of manual and semi-automated validation using registry-based data of breast cancer patients in the Netherlands
by: Cornelia D. van Steenbeek, et al.
Published: (2019-06-01) -
The value of time-dependent risk predictions in a screening context - a comprehensive simulation analysis validated on German cancer registry data
by: Vinzenz Voelkel, et al.
Published: (2022-09-01) -
A conditional model predicting the 10-year annual extra mortality risk compared to the general population: a large population-based study in Dutch breast cancer patients.
by: Marissa C van Maaren, et al.
Published: (2019-01-01)